Skip to main content
SpringerLink
Log in
Book cover

Hypertension in High Risk African Americans pp 233–249Cite as

Hypertension in African Americans

  • Chapter
  • First Online:

  • 733 Accesses

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Hypertension in African Americans has been characterized by earlier onset, greater severity, higher prevalence, and significantly greater risk for pressure-related clinical complication such as stroke, heart failure, myocardial infarction (MI), and chronic kidney disease (CKD)/end-stage renal disease (ESRD) relative to whites. Awareness and treatment rates of hypertension are slightly higher in African Americans, but control rates are lower than amongst whites. Salt sensitivity and non-dipping nocturnal BP are common intermediate BP phenotypes. Vitamin D deficiency is pervasive in African Americans, and supplementation with vitamin D appears to lower BP in this population.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Guo F, et al. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599–606.

    Article  PubMed  Google Scholar 

  2. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6(6):497–502.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Heffernan KS, et al. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295(6):H2380–7.

    Article  PubMed  Google Scholar 

  4. Neal L, Greene EL. Pathophysiology of chronic progressive renal disease in the African American patient with hypertension. Am J Med Sci. 2002;323(2):72–7.

    Article  PubMed  Google Scholar 

  5. Stein CM, et al. Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clin Pharmacol Ther. 1997;62(4):436–43.

    Article  CAS  PubMed  Google Scholar 

  6. Zion AS, et al. Low arterial compliance in young African-American males. Am J Physiol Heart Circ Physiol. 2003;285(2):H457–62.

    CAS  PubMed  Google Scholar 

  7. East MA, et al. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J. 2004;148(1):151–6.

    Article  PubMed  Google Scholar 

  8. Flack JM, et al. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993;21(4 Suppl 1):31–40.

    Article  CAS  PubMed  Google Scholar 

  9. Mensah GA, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111(10):1233–41.

    Article  PubMed  Google Scholar 

  10. Centers for Disease Control (CDC). Compressed Mortality file: underlying cause of death. National Center for Health Statistics. 2008. http://wonder.cdc.gov/mortsql.html, 2009.

  11. Hughes JW, Kobayashi I, Deichert NT. Ethnic differences in sleep quality accompany ethnic differences in night-time blood pressure dipping. Am J Hypertens. 2007;20(10):1104–10.

    Article  PubMed  Google Scholar 

  12. Sica DA. What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure? Blood Press Monit. 1999;4 Suppl 2:S9–16.

    PubMed  Google Scholar 

  13. Mojon A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1–2):145–58.

    Article  CAS  PubMed  Google Scholar 

  14. Ayala DE, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30(1–2):99–115.

    Article  PubMed  Google Scholar 

  15. Hermida RC, et al. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 2013;30(1–2):176–91.

    Article  PubMed  Google Scholar 

  16. DasGupta P, et al. Circadian variation and blood pressure: response to rapid weight loss by hypocaloric hyponatraemic diet in obesity. J Hypertens. 1991;9(5):441–7.

    Article  CAS  PubMed  Google Scholar 

  17. Wilson DK, Sica DA, Miller SB. Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents. Am J Hypertens. 1999;12(2 Pt 1):159–65.

    Article  CAS  PubMed  Google Scholar 

  18. Ziegler MG. Sleep disorders and the failure to lower nocturnal blood pressure. Curr Opin Nephrol Hypertens. 2003;12(1):97–102.

    Article  PubMed  Google Scholar 

  19. Flack JM, et al. Racial and ethnic modifiers of the salt-blood pressure response. Hypertension. 1991;17(1 Suppl):I115–21.

    Article  CAS  PubMed  Google Scholar 

  20. Morris Jr RC, et al. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension. 1999;33(1):18–23.

    Article  CAS  PubMed  Google Scholar 

  21. Damasceno A, et al. Influence of salt intake on the daytime-nighttime blood pressure variation in normotensive and hypertensive black subjects. Rev Port Cardiol. 2000;19(3):315–29.

    CAS  PubMed  Google Scholar 

  22. Schmidlin O, et al. Sodium-selective salt sensitivity: its occurrence in blacks. Hypertension. 2007;50(6):1085–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Schmidlin O, Sebastian AF, Morris Jr RC. What initiates the pressor effect of salt in salt-sensitive humans? Observations in normotensive blacks. Hypertension. 2007;49(5):1032–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Schmidlin O, et al. Salt sensitivity in blacks: evidence that the initial pressor effect of NaCl involves inhibition of vasodilatation by asymmetrical dimethylarginine. Hypertension. 2011;58(3):380–5.

    Article  CAS  PubMed  Google Scholar 

  25. Schmidlin O, et al. NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension. 1999;33(2):633–9.

    Article  CAS  PubMed  Google Scholar 

  26. Lloyd-Jones DM, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.

    Article  PubMed  Google Scholar 

  27. US Department of Health and Human Services, USDA. Dietary guidelines for Americans, 2010. 7th ed. Washington, DC: USDA; 2011.

    Google Scholar 

  28. Institute of Medicine (IOM). Sodium intake in populations: assessment of the evidence. Washington, DC: The National Academies Press; 2013. http://www.nap.edu/

  29. Cogswell ME, et al. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr. 2012;96(3):647–57.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Tobian L, et al. High-K diets reduce brain haemorrhage and infarcts, death rate and mesenteric arteriolar hypertrophy in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl. 1986;4(5):S205–7.

    CAS  PubMed  Google Scholar 

  31. Aburto NJ, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378.

    Article  PubMed  Google Scholar 

  32. Guardia G, et al. Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int. 2008;19(1):13–9.

    Article  CAS  PubMed  Google Scholar 

  33. Nesby-O’Dell S, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76(1):187–92.

    PubMed  Google Scholar 

  34. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20(7):713–9.

    Article  CAS  PubMed  Google Scholar 

  35. Engelman CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008;93(9):3381–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics. 2009;123(3):797–803.

    Article  PubMed  Google Scholar 

  37. Gupta AK, Brashear MM, Johnson WD. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care. 2011;34(3):658–60.

    Article  PubMed Central  PubMed  Google Scholar 

  38. He JL, Scragg RK. Vitamin D, parathyroid hormone, and blood pressure in the National Health and Nutrition Examination Surveys. Am J Hypertens. 2011;24(8):911–7.

    Article  CAS  PubMed  Google Scholar 

  39. Griffin FC, Gadegbeku CA, Sowers MR. Vitamin D and subsequent systolic hypertension among women. Am J Hypertens. 2011;24(3):316–21.

    Article  CAS  PubMed  Google Scholar 

  40. Valina-Toth AL, et al. Vitamin D and parathyroid hormone relationships with urinary nitric oxide metabolites and plasma isoprostanes in African-Americans. Cardiorenal Med. 2012;2(3):234–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Bouillon R, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726–76.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Li YC, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229–38.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Yuan W, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821–30.

    Article  CAS  PubMed  Google Scholar 

  44. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KW, Giovannucci EL, Fuchs CS, Chan AT. Effect of Vitamin D supplementation on blood pressure in blacks. Hypertension 2013;61(4):779-85.

    Google Scholar 

  45. Allen N, et al. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation. 2012;125(1):37–44.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Flack JM, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800.

    Article  CAS  PubMed  Google Scholar 

  47. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Jamerson K, et al. Benazepril plus amLodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417–28.

    Article  CAS  PubMed  Google Scholar 

  49. American Diabetes Association (ADA). Standards of medical care in diabetes—2013. Diabetes Care. 2013;36 Suppl 1:S11–66.

    Article  Google Scholar 

  50. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85.

    Article  Google Scholar 

  51. Schrier RW, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61(3):1086–97.

    Article  PubMed  Google Scholar 

  52. Zhang X, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304(6):649–56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Dagenais GR, et al. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001;104(5):522–6.

    Article  CAS  PubMed  Google Scholar 

  54. Whelton PK, et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(12):1401–9.

    Article  CAS  PubMed  Google Scholar 

  55. Appel LJ, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918–29.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Wright Jr JT, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421–31.

    Article  CAS  PubMed  Google Scholar 

  57. Rahman M, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(8):936–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Translational Research and Clinical Epidemiology, Department of Medicine, Wayne State University, 4201 St. Antoine, Suite 2E-University Health Center, Detroit, MI, 48201, USA

    John M. Flack M.D., M.P.H. & Brian A. Ference M.D., M.Phil., M.Sc.

  2. Division of Endocrinology, Metabolism and Hypertension, Department of Medicine, Wayne State University, Detroit, MI, USA

    John M. Flack M.D., M.P.H.

  3. Department of Physiology, Department of Medicine, Wayne State University, Detroit, MI, USA

    John M. Flack M.D., M.P.H.

  4. Division of Cardiology, Department of Medicine, Wayne State University, Detroit, MI, 48201, USA

    Brian A. Ference M.D., M.Phil., M.Sc.

  5. Department of Emergency Medicine, Department of Medicine, Wayne State University, Detroit, MI, 48201, USA

    Phillip Levy M.D., M.P.H.

Authors
  1. John M. Flack M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian A. Ference M.D., M.Phil., M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Phillip Levy M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Flack M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Flack, J.M., Ference, B.A., Levy, P. (2015). Hypertension in African Americans. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_15

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation